Therefore, further investigation into the mechanisms underlying STING pathway inactivation and strategies to activate this pathway is crucial for enhancing the sensitivity of gastric cancer cells to cisplatin, providing new therapeutic strategies for overcoming chemotherapy resistance in gastric cancer. This evidence concerns the gene STING1 and gastric cancer.